Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
18 August 2025 - preview of changes for September 2025
|
Pharmaceutical |
Change |
|---|---|
|
Abacavir sulphate with lamivudine (Abacavir/lamivudine Viatris) tab 600 mg with lamivudine 300 mg |
price increase and addition of PSS |
|
Aciclovir (Lovir) tab dispersible 200 mg, 400 mg and 800 mg |
price increase and addition of PSS |
|
Adalimumab (Amgevita) inj 20 mg per 0.4 ml |
amended restriction criteria |
|
Amiodarone hydrochloride
|
price increase and addition of PSS |
|
Amino acid formula (without phenylalanine and |
new listing (p’code 2711443) |
|
Amino acid formula (without phenylalanine and |
to be delisted 1 December 2025 |
|
Amoxicillin (Miro-Amoxicillin) cap 250 mg |
price increase and addition of PSS |
|
Aspirin (Ethics Aspirin EC) tab 100 mg, 90 tab pack |
delisted 1 September 2025 |
|
Atazanavir sulphate (Atazanavir Viatris) cap 150 mg and 200 mg |
price increase and addition of PSS
|
|
Azathioprine (Azamun) tab 25 mg and 50 mg |
price increase and addition of PSS |
|
Benzathine benzylpenicillin (Benzetacil) inj 900 mg (1.2 million units) vial |
new listing (p’code 2711753) |
|
Benzatropine mesylate (Benztrop) tab 2 mg |
price increase |
|
Bupivacaine hydrochloride with fentanyl (Bupafen) inj 1.25 mg with fentanyl 2 mcg per ml, 100 ml bag and 200 ml bag |
price increase and addition of PSS |
|
Capecitabine (Capecitabine Viatris) tab 150 mg and 500 mg |
price increase and addition of PSS |
|
Carbamazepine (Tegretol AU) tab 200 mg |
delisted 1 September 2025 |
|
Cefaclor (Ranbaxy-Cefaclor) cap 250 mg and grans for oral liq 25 mg per ml, 100 ml |
price increase and addition of PSS |
|
Ceftriaxone (Ceftriaxone-AFT) inj 500 mg vial and |
price increase and addition of PSS |
|
Ceftriaxone (Ceftriaxone-AFT) inj 1 g vial |
price decrease and addition of PSS |
|
Celecoxib cap 100 mg
|
Brand change
|
|
Charcoal (Carbosorb-X) oral liq 200 mg per ml, 250 ml |
price increase |
|
Chloramphenicol (Devatis) eye oint 1%, 5 g |
price increase and addition of PSS |
|
Chlortalidone [chlorthalidone] (Hygroton) tab 25 mg |
addition of PSS |
|
Clobetasol propionate (Dermol) crm and oint 0.05%, 30 g and scalp app 0.05%, 30 ml |
price increase and addition of PSS |
|
Clonidine hydrochloride (Clonidine Teva) tab 25 mcg |
price increase and addition of PSS |
|
Diatrizoate meglumine with sodium amidotrizoate (Gastrografin) oral liq 660 mg per ml with sodium amidotrizoate 100 mg per ml, 100 ml bottle |
new Pharmacode listing (p’code 2698730) |
|
Digoxin tab 62.5 mcg (Lanoxin PG) and tab 250 mcg (Lanoxin) |
price increase and addition of PSS |
|
Dihydrocodeine tartrate (DHC Continus) tab long-acting 60 mg |
price increase and addition of PSS |
|
Dipyridamole (Dipyridamole – Strides) cap |
new listing (p’code 2710919) |
|
Dipyridamole tab 25 mg, inj 5 mg per ml 2 ml |
addition of restriction |
|
Droperidol inj 2.5 mg per ml, 1 ml ampoule |
Brand change
|
|
Emulsifying ointment (Evara Emulsifying Ointment) oint BP, 500 g |
amended brand name |
|
Ferrous sulfate (Ferrograd) tab long-acting 325 mg (105 mg elemental) |
addition of restriction and to be delisted 1 March 2026 |
|
Ferrous sulfate oral liq 30 mg (6 mg elemental) per 1 ml, 250 ml |
Brand change
|
|
Fexofenadine hydrochloride (Fexaclear) tab 120 mg |
Pharmacode change
|
|
Gentamicin sulphate (Cidomycin P/Free, |
to be delisted 1 December 2025 |
|
Glycerol (Lax-suppositories Glycerol) suppos 2.8/4.0 g |
price increase and addition of PSS |
|
Heparin sodium
|
to be delisted 1 January 2026 |
|
Hydrocortisone (Noumed) crm 1%, 500 g |
addition of PSS |
|
Labetalol (Presolol) tab 200 mg |
new listing (p’code 2565579) |
|
Lactulose (Laevolac) oral liq 10 g per 15 ml, 500 ml |
price increase and addition of PSS |
|
Lenalidomide (Viatris) (Lenalidomide Viatris) cap |
new Pharmacode listing (p’code 2707527) |
|
Lidocaine [lignocaine] hydrochloride gel 2%, 11 ml urethral syringe (Instillagel Lido) and spray 10%, 50 ml (Xylocaine) |
price increase and addition of PSS |
|
Liothyronine sodium inj 10 mcg vial |
new listing |
|
Loperamide hydrochloride (Diamide Relief) cap |
price increase and addition of PSS |
|
Methadone hydrochloride (AFT) inj 10 mg per ml, |
price increase |
|
Meningococcal B multicomponent vaccine |
amended restriction criteria |
|
Morphine sulphate (Medsurge) inj 5 mg, 10 mg, 15 mg and 30 mg per ml, 1 ml ampoule |
price increase and addition of PSS |
|
Neostigmine metilsulfate with glycopyrronium bromide (Max Health) inj 2.5 mg with glycopyrronium bromide 0.5 mg per ml, 1 ml ampoule |
addition of PSS |
|
Nicorandil (Max Health) tab 10 mg and 20 mg |
price increase and addition of PSS |
|
Nimodipine (Nimotop) tab 30 mg and inj 0.2 mg per ml, 50 ml vial |
addition of PSS
|
|
Noradrenaline inj 1 mg per ml, 4 ml ampoule
|
Brand change
|
|
Ondansetron (Ondansetron-AFT) inj 2 mg per ml, 2 ml and 4 ml ampoule |
price increase and addition of PSS |
|
Oral feed (Sustagen Hospital Formula (Chocolate and Vanilla)) powder 23 g protein, 65 g carbohydrate and 2.5 g fat per 100 g, can, 840 g |
price increase |
|
Oxycodone hydrochloride (Oxycodone Amneal)
|
delisted 1 September 2025 |
|
Oxytocin with ergometrine maleate (Syntometrine) inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml ampoule |
price increase and addition of PSS |
|
Paracetamol (Paracetamol Kabi) inj 10 mg per ml, 100 ml vial |
price increase and addition of PSS |
|
Paracetamol with codeine (Paracetamol + Codeine (Relieve)) tab paracetamol 500 mg with codeine phosphate 8 mg |
price increase and addition of PSS |
|
Paroxetine (Loxamine) tab 20 mg |
price increase and addition of PSS |
|
Paroxetine (Paxtine) tab 20 mg |
new listing (p’code 2600188) |
|
Pegfilgrastim (Ziextenzo) inj 6 mg per 0.6 ml |
price increase and addition of PSS |
|
Pethidine hydrochloride (Noumed Pethidine) tab 50 mg |
addition of PSS |
|
Phenoxymethylpenicillin [Penicillin V] (AFT) grans for oral liq 125 mg per 5 ml and grans for oral liq 250 mg per 5 ml, 100 ml |
price increase and addition of PSS |
|
Potassium chloride (Span-K) tab long-acting 600 mg (8 mmol) |
price increase and addition of PSS |
|
Propofol (Fresofol 1% MCT/LCT) inj 10 mg per ml, 20 ml ampoule, 50 ml vial and 100 ml vial |
price increase and addition of PSS |
|
Remdesivir (Veklury) inj 100 mg vial |
price decrease, amended note and removal of restriction criteria |
|
Risedronate sodium (Risedronate Sandoz) tab 35 mg |
price increase and addition of PSS |
|
Rivastigmine patch 4.6 mg per 24 hour (Rivastigmine Patch BNM 5) and patch 9.5 mg per 24 hour (Rivastigmine Patch BNM 10) |
amended restriction criteria |
|
Salbutamol (UK Cipla) nebuliser soln 2 mg per ml, 2.5 ml ampoule |
new listing (p’code 2712199) |
|
Sodium citrate with sodium lauryl sulphoacetate (Micolette) enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml |
price increase and addition of PSS |
|
Sodium chloride (Fresenius Kabi) inj 0.9%, 5 ml, 10 ml and 20 ml ampoule |
price increase and addition of PSS |
|
Sotalol (Mylan) tab 80 mg and 160 mg |
price increase and addition of PSS |
|
Tamsulosin hydrochloride (Tamsulosin-Rex) cap 400 mcg |
price increase and addition of PSS |
|
Tenoxicam (Tilcotil) tab 20 mg |
price increase and addition of PSS |
|
Tetrabenazine (Motetis) tab 25 mg |
price increase and addition of PSS |
|
Vinorelbine (Vinorelbine Te Arai) cap 20 mg, 30 mg and 80 mg |
price increase and addition of PSS |
|
Zoledronic acid (Zoledronic Acid Viatris) inj 5 mg per 100 ml, bag |
price decrease and addition of PSS |